A group of Brazilian researchers developed a molecular test that can diagnose very effectively the zika in up to five hours and will begin to be implemented next Monday to facilitate studies on methods to combat this virus, academic sources said Monday.
EFE
The survey, with 100% efficiency, detects zika both blood samples and saliva and urine, reported the University of Campinas (Unicamp), whose scientific innovation developed in partnership with colleagues from the University of Sao Paulo (USP ) and the University of the State of Sao Paulo (Unesp).
The test will be used from Monday to analyze samples from patients with suspected zika treated at the Hospital das Clinicas, Campinas, a city in the interior of Sao Paulo.
Samples found positive shall be conducted in Brazilian laboratories where zika is studied so that the virus can be isolated and used in projects to decode the genetic sequence of the virus and other research that could give clues tools to combat it.
The test, developed by the researchers created a week ago by Unicamp, USP and Unesp to combat the disease, can differentiate zika dengue and chikungunya, the other two viruses transmitted by the "Aedes aegypti" mosquito.
The test will allow to replace the two that are currently used and take several days to diagnose the disease, among which it is distributed by the Ministry of Health and can detect zika in blood samples from up to five days or samples urine up to eight days.
The other test, serological, determines whether a blood sample contains antibodies that the human body produces to fight off the virus.
The rapid development of new test was made possible by the information that Brazilian scientists received Senegalese who entered the country in January to help Brazil fight zika.
"They gave us all the information we already have about how the virus works and how it can be diagnosed," said Matehus Martini, a researcher at Unicamp and one of those responsible for innovation.
The research coordinator, Arns Clarice, also a researcher at Unicamp, said the test may be applied in samples of patients from other cities when the group has the resources to finance its high cost.
The Brazilian government said last year alertness by increasing the number of cases of microcephaly among newborns, a malformation whose strong growth is attributed by some authorities to the spread of zika.
The World Health Organization (WHO) also declared a public health emergency of international concern about cases of microcephaly and neurological disorders appeared in Brazil, but not Zika virus, as it was not proven their relationship.
Brazil launched an intensive campaign to eliminate nationwide potential breeding mosquito larvae, for now the only weapon available to combat the "Aedes aegypti" diseases.
EFE
The survey, with 100% efficiency, detects zika both blood samples and saliva and urine, reported the University of Campinas (Unicamp), whose scientific innovation developed in partnership with colleagues from the University of Sao Paulo (USP ) and the University of the State of Sao Paulo (Unesp).
The test will be used from Monday to analyze samples from patients with suspected zika treated at the Hospital das Clinicas, Campinas, a city in the interior of Sao Paulo.
Samples found positive shall be conducted in Brazilian laboratories where zika is studied so that the virus can be isolated and used in projects to decode the genetic sequence of the virus and other research that could give clues tools to combat it.
The test, developed by the researchers created a week ago by Unicamp, USP and Unesp to combat the disease, can differentiate zika dengue and chikungunya, the other two viruses transmitted by the "Aedes aegypti" mosquito.
The test will allow to replace the two that are currently used and take several days to diagnose the disease, among which it is distributed by the Ministry of Health and can detect zika in blood samples from up to five days or samples urine up to eight days.
The other test, serological, determines whether a blood sample contains antibodies that the human body produces to fight off the virus.
The rapid development of new test was made possible by the information that Brazilian scientists received Senegalese who entered the country in January to help Brazil fight zika.
"They gave us all the information we already have about how the virus works and how it can be diagnosed," said Matehus Martini, a researcher at Unicamp and one of those responsible for innovation.
The research coordinator, Arns Clarice, also a researcher at Unicamp, said the test may be applied in samples of patients from other cities when the group has the resources to finance its high cost.
The Brazilian government said last year alertness by increasing the number of cases of microcephaly among newborns, a malformation whose strong growth is attributed by some authorities to the spread of zika.
The World Health Organization (WHO) also declared a public health emergency of international concern about cases of microcephaly and neurological disorders appeared in Brazil, but not Zika virus, as it was not proven their relationship.
Brazil launched an intensive campaign to eliminate nationwide potential breeding mosquito larvae, for now the only weapon available to combat the "Aedes aegypti" diseases.